Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH, Sio KM, Wu CH, Xia YY, Lee JJ, Hu CH, Liu CC, Lu CL, Cheng CL, Lin KH, Tomiyasu H, Wang YS, Lin CS.
J Vet Intern Med. 2023 Nov-Dec;37(6):2391-2401. doi: 10.1111/jvim.16898. Epub 2023 Oct 14.
D-dimers (DD) in CVST.
Wang HF, Pu CQ, Yin X, Tian CL, Chen T, Guo JH, Shi Q.
Int J Neurosci. 2017 Jun;127(6):524-530. doi: 10.1080/00207454.2016.1207172. Epub 2016 Jul 17.
Exciting Performance of Plasma Fibrinogen in Periprosthetic Joint Infection Diagnosis.
Huang JC, Chen X, Qiang S, Zheng WD, Zheng J, Jin Y.
Orthop Surg. 2021 May;13(3):812-816. doi: 10.1111/os.12964. Epub 2021 Mar 15.
Dyslipidemias and fibrinolysis.
Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Auteri A.
Ital Heart J. 2002 Oct;3(10):579-86.
[Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
Rinsho Byori. 2001 Mar;49(3):283-9.
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR.
Thromb Res. 1995 May 15;78(4):353-62. doi: 10.1016/0049-3848(95)91463-u.
Finding the Optimal Screening Test for Periprosthetic Joint Infection: A Prospective Study.
Tarabichi S, Lizcano JD, Abe EA, Goh GS, Baker CM, Parvizi J.
J Arthroplasty. 2024 Aug;39(8):1919-1925.e2. doi: 10.1016/j.arth.2024.02.030. Epub 2024 Mar 6.
Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma.
Okholm M, Iversen LH, Thorlacius-Ussing O, Ejlersen E, Boesby S.
Dis Colon Rectum. 1996 Oct;39(10):1102-6. doi: 10.1007/BF02081408.
[D-dimer levels in venous thromboembolism].
Soto MJ, Monreal M.
Med Clin (Barc). 2005 May 21;124(19):749-53. doi: 10.1157/13075461.
Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.
Moresco RN, Júnior RH, Cláudio Rosa Vargas L, Mariano da Rocha Silla L.
J Thromb Thrombolysis. 2006 Apr;21(2):199-202. doi: 10.1007/s11239-006-4837-9.
